Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 359-365 , March 2006

The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin

  • Alena Dvořáková-Lorenzová

      Affiliations

    • Laboratory for Atherosclerosis Research, Centre for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +42 0 608889385.
    • ,
  • Pavel Suchánek

      Affiliations

    • Laboratory for Atherosclerosis Research, Centre for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
    • ,
  • Peter J. Havel

      Affiliations

    • Department of Nutrition, University of California, Davis, CA 95616, USA
    • ,
  • Petr Stávek

      Affiliations

    • Laboratory for Atherosclerosis Research, Centre for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
    • ,
  • Ludmila Karasová

      Affiliations

    • Laboratory of Radioisotope Diagnostics, Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
    • ,
  • Zdenĕk Valenta

      Affiliations

    • EuroMISE Center, Institute of Computer Science AS CR, Prague 180 00, Czech Republic
    • ,
  • Jaroslav Tintĕra

      Affiliations

    • Magnetic Resonance Department, Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
    • ,
  • Rudolf Poledne

      Affiliations

    • Laboratory for Atherosclerosis Research, Centre for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic

Received 12 April 2005 ,Accepted 20 September 2005.

References 

  1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular mortality in middle aged men. JAMA. 2002;288:2709–2716
  2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–118
  3. Rifai N, Ridker PM. Inflammatory markers and coronary heart disease. Curr Opin Lipidol. 2002;13:383–389
  4. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  5. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study; 1984 to 1992. Circulation. 1999;99:237–242
  6. Yudkin JS, Stehouwer CH, Emeis JJ, et al. C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  7. Festa A, D'Agostino RJ, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–47
  8. Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation. 2004;109:2818–2825
  9. Tchernof A, Nolan A, Sites CK, et al. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002;105:564–569
  10. Heilbronn LK, Clifton PM. C-Reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. J Nutr Biochem. 2002;13:316–321
  11. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes. 2002;26:659–662
  12. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA. 2003;289:1799–1804
  13. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042–1047
  14. Pannacciulli N, Cantatore FP, Mienna A, et al. Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Intern Med. 2001;250:502–507
  15. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis?. Eur Heart J. 2002;23:831–834
  16. McGill HC, McMahan A, Herderck EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712–2718
  17. Suchanek P, Tintera J, Dvorakova A, et al. Decrease in subcutaneous and intraabdominal fat by lifestyle intervention of young obese women. Phys Res [in press].
  18. Novak M. Colorimetric ultramicro method for the determination of free fatty acids. J Lipid Res. 1965;6:431–433
  19. Tintera J, Harantova P, Suchanek P, et al. Quantification of intra-abdominal fat during controlled weight reduction: assessment using water suppressed breath-hold MRI technique. Physiol Res. 2004;53:229–234
  20. Franks PW, Wong MY, Luan J, et al. Non-esterified fatty acid levels and physical inactivity: the relative importance of low habitual energy expenditure and cardiorespiratory fitness. Br J Nutr. 2002;88:307–313
  21. Rennie K, McCarthy N, Yazdgerdi S, et al. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol. 2003;32:600–606
  22. McLaughlin T, Abbasi F, Lamendola C, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002;106:2908–2912
  23. Writing Group of the PREMIER Collaborative Research Group. Effect of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–2093
  24. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens. 2003;17:223–230
  25. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interlekin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847–850
  26. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549–2557
  27. Keller C, Keller P, Marshal S, et al. IL-6 gene expression in human adipose tissue in response to exercise—effect of carbohydrate ingestion. J Physiol. 2003;550:927–931
  28. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53(Suppl 1):S143–S151
  29. Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999;38:202–206
  30. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487–37491
  31. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E–deficient mice. Circulation. 2002;106:2767–2770
  32. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–469
  33. Schulze MB, Rimm EB, Shai I, et al. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004;27:1680–1687
  34. Xydakis AM, Case CC, Jones PH, et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals; the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab. 2004;89:2697–2703
  35. Faraj M, Havel PJ, Phalis S, et al. Plasma acylation-stimulating protein adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–1602
  36. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279:12152–12162
  37. Silvestri A, Gebara O, Vitale C, et al. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation. 2003;107:3165–3169

PII: S0026-0495(05)00367-7

doi: 10.1016/j.metabol.2005.09.010

Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 359-365 , March 2006

Article Tools

* Image Usage & Resolution